Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

Haematologica. 2017 Nov;102(11):e443-e446. doi: 10.3324/haematol.2017.170340. Epub 2017 Jul 27.

¹ Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy [email protected].
² Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
³ Division of Hematology - Department of Translational Medicine - Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
⁴ Division of Hematology, Ferrarotto Hospital, Catania, Italy.
⁵ Department of Hematology, Mayo Clinic, Rochester, MN, USA.
⁶ Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
⁷ IRCCS, Referral Cancer Center of Basilicata, Potenza, Italy.
⁸ Oncologia Medica A IRCCS, Centro di Riferimento Oncologico, Aviano, Italy.
⁹ Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy.
¹⁰ Department of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Italy.
¹¹ Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.

No abstract available

Publication types